A global leader in digital diagnostics and the first company to receive FDA approval for an AI-based digital pathology product, Paige utilizes powerful AI to build computational pathology products that enable standardized detection and quantification of tumors pre- or post- treatment. Providing additional insights from tissue, Paige supports pathologists and researchers make more informed decisions on treatment and trial options that can optimize patient outcomes.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes